Simplex Trading’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,213
Closed -$23K 10594
2022
Q1
$23K Buy
2,213
+246
+13% +$2.81K ﹤0.01% 8089
2021
Q4
$24K Sell
1,967
-593
-23% -$9.15K ﹤0.01% 8152
2021
Q3
$60K Buy
2,560
+273
+12% +$5.35K ﹤0.01% 7299
2021
Q2
$55K Buy
2,287
+2,277
+22,770% +$54K ﹤0.01% 7532
2021
Q1
$30K Sell
10
-3
-23% -$91 ﹤0.01% 7127
2020
Q4
$27K Sell
13
-3
-19% -$71 ﹤0.01% 6749
2020
Q3
$43K Buy
16
+14
+700% +$443 ﹤0.01% 5751
2020
Q2
$6K Buy
2
+1
+100% +$29 ﹤0.01% 6894
2020
Q1
$3K Hold
1
﹤0.01% 7070
2019
Q4
$5K Buy
+1
New +$36 ﹤0.01% 6696
2019
Q1
Sell
-2
Closed -$12K 7513
2018
Q4
$12K Hold
2
﹤0.01% 5733
2018
Q3
$21K Buy
+2
New +$164 ﹤0.01% 5924
2018
Q2
Hold
0
7041
2016
Q1
Hold
0
-$20K 5944
2015
Q4
Hold
0
2692
2015
Q3
Hold
0
3200
2015
Q2
Hold
0
4304
2015
Q1
Hold
0
-$7K 5294
2014
Q4
Hold
0
2851

Other funds holding LSTA

Simplex Trading's LSTA Position: Q2 2022 in Review

Simplex Trading sold out of Lisata Therapeutics (LSTA) in Q2 2022, closing a stake of 1,259 shares — an estimated $10.4K sold.

Simplex Trading first reported a position in LSTA in Q4 2014 and held it in 10 quarters. The position peaked at $21K in Q4 2020. 34 funds tracked by Wall St. Rank hold LSTA as of Q2 2022.

  • Simplex Trading reported no remaining Lisata Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 1,259 Lisata Therapeutics shares in Q2 2022, an estimated $10.4K.
  • Simplex Trading first reported a position in Lisata Therapeutics in Q4 2014 and held it in 10 quarters.
  • Simplex Trading's Lisata Therapeutics position peaked at $21K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.